Stock Watch Lists

Rising Stars: Three “Unicorns” Set to Disrupt the Market

September 26, 2023

The term “unicorn” refers to a privately owned startup valued at over $1 billion. Reaching unicorn status is a rare feat. In order to become one, a company must have an innovative idea, a clear vision for growth, and a solid business plan, as well as a viable way to get its message to venture capitalists and private investors.

The term was coined by Aileen Lee, who noted that only a mere 0.07% of 2000s software startups reached this status. She likened finding one to spotting a mythical unicorn. The concept emerged in the 1990s, with Google standing out as a “super-unicorn,” boasting a $100 billion valuation. The 2000s also witnessed the rise of unicorns, but only Meta (formerly Facebook) achieved super-unicorn status. Other notable U.S. unicorns include Airbnb, Epic Games, Robinhood, and SoFi.

In this list, we’ll look at three private companies that are chasing some of the market’s biggest opportunities and growing despite a tough capital markets environment and a slowing economy.

Investors who track the growth of these innovators as they journey towards their IPOs stand the best chance for exponential gains once the company becomes public. So ride the wave of opportunity with us, and watch for your chance to get in on the ground floor of the next Google or Meta.

Wiz

Founders: Assaf Rappaport (CEO), Ami Luttwak, Yinon Costica, Roy Reznik

Launched: 2020

Headquarters: New York City

Funding: $900 million

Valuation: $10 billion

Key technologies: Cloud computing

Industry: Enterprise technology

From the heart of Tel Aviv, hyper-growth sensation, Wiz, is setting an ambitious course to achieve a remarkable $100 million in revenue within a mere 18-month span. Wiz stands at the forefront as a trailblazer in the realm of cybersecurity, introducing an innovative approach that swiftly identifies and addresses cyber risks, all while paving the way for a novel category of cloud-centric security solutions.

Wiz’s recent exponential growth surge can be attributed to a constellation of factors, including the strategic launch of new cutting-edge products, strategic partnerships with heavyweight names like BMW and Salesforce, and the privilege of serving a substantial segment of the Fortune 100 echelon.

This unfolding narrative coincides with the cloud’s transformation, transcending the confines of mere computing access and storage to profoundly influence the cybersecurity landscape. Consequently, the surge in demand for cloud-centric security is a palpable testament to the evolving cyber landscape.

Spring Health

Founders: April Koh (CEO), Adam Chekroud

Launched: 2016

Headquarters: New York City

Funding: $300 million

Valuation: $2.5 billion

Key technologies: Artificial intelligence

Industry: Health care

In the ever-evolving landscape of workplace dynamics, the spotlight has shone resolutely on mental health and worker well-being, catalyzed by the pandemic’s transformative impact on remote work trends. With a keen eye on the tight labor market, where optimal employee productivity stands as a vital linchpin, employers are increasingly channeling their focus towards addressing stress, anxiety, depression, and the looming specter of burnout. Stepping into this narrative is Spring Health, a herald of the new generation of mental health providers poised to extend their support to employers and health plans.

Spring Health’s journey began as an academic research endeavor over at Yale University. From there, it transformed into something truly remarkable. Armed with clinically validated data, Spring Health emerged as a force to reckon with. They’re tapping into the precision medicine trend, leveraging their platform to deliver exactly what each person needs. Whether it’s meditation, coaching, therapy, medication, or a mix of these, they’re all about personalized solutions.

April Koh, the co-founder and CEO, has a powerful story behind this approach. After witnessing loved ones struggling with different providers, programs, and medications without success, she decided to take a bold, data-driven route. And you know what? She’s absolutely onto something. In her own words, “Every setback chips away at one’s courage and hope. In five to ten years, the landscape of mental health care will undergo a paradigm shift. It will evolve from the realm of uncertainty to one marked by precision, driven by data, tailored to each individual,” as she shared on the company’s website.

In the here and now, Spring Health has seamlessly woven its expertise into the fabric of over 800 companies spanning startups to global Fortune 500 stalwarts, counting General Mills, Bain, and Instacart among its beneficiaries. Notably, 2022 witnessed its portfolio welcoming the likes of Microsoft, JPMorgan Chase, and Trinity Health. The acquisition of family wellness platform Weldon, unveiled in May, was a strategic stride to offer more holistic services, touching aspects such as sleep, behavior, conflicts, grief, developmental challenges, and neurodiversity within families. The canvas of its influence expanded across 40 countries and 20 languages, and the company raised $71 million in April, constituting a quarter of its overall capital raised.

Relativity Space

Founder: Tim Ellis (CEO), Jordan Noone

Launched: 2015

Headquarters: Long Beach, California

Funding: $1.3 billion

Valuation: $4.2 billion

Key technologies: Artificial intelligence, machine learning, robotics, digital twins

Industry: Aerospace, transportation

Relativity Space has made its mark by launching a 3D-printed rocket from Cape Canaveral, Florida this March. Now, while the initial test flight didn’t quite reach orbit, this space startup isn’t slowing down. Their mission? To revolutionize rocket manufacturing, making it cheaper and faster for upcoming journeys to the moon and Mars.

Billionaire investor and entrepreneurial virtuoso Mark Cuban has backed Relativity since its initial round of funding 2016, extending his patronage in successive funding rounds. This symphony of support harmonizes with the backing of Tiger Global, BOND, and Fidelity Research and Management, all conducted under the baton of Relativity Space’s magnetic allure. In a crescendo of investment, the startup resonated with a $650 million raise in its fifth funding cycle during June 2021, magnifying its valuation to the exalted echelons of $4.2 billion.

While Relativity Space’s spotlight spans from commercial pioneers to the resolute arm of the U.S. government, the apex of recognition comes courtesy of NASA. In 2022, this pioneering entity penned a twenty-year partnership with NASA’s Stennis Space Center in Mississippi, unfurling a new chapter in growth.

Stock Hotlist: Top Picks to Watch Now

Editorial Staff

September 22, 2023

Picking the wrong stocks can decimate your portfolio.

They’re pure portfolio poison.

But the right stocks…

If you pick the right stocks, you could find yourself jumping for joy on top of an enormous pile of cash.

With over 4000 tickers to choose from, finding the right stock at the right time can prove to be nearly impossible…

Unless you’re spending hours each day combing the markets and researching companies.

That’s why we’ve done the legwork for you.

We sort through thousands of stock ideas and whittle them down to a few top choices that are primed for solid price action in the coming days, weeks and months.

This week, we’ve narrowed it down to three stocks that could be getting significant attention in the near future.

Curaleaf Holdings (CURLF)

If marijuana receives reclassification as Schedule III, it could usher in a new era for medical cannabis, aligning it with pharmaceutical regulations. This transformation would be particularly advantageous for companies like Green Thumb and Curaleaf, both of which operate in this space.

Curaleaf, boasting a market cap of $4.8 billion, has experienced a remarkable 64% surge since late August. Much like Green Thumb, Curaleaf operates as a multi-state operator, with a presence in 20 states. The company manages 22 cultivation sites and 152 retail outlets, positioning itself for international expansion through strategic acquisitions. For instance, in the fourth quarter of 2022, Curaleaf secured a 55% equity stake in Four 20 Pharma, a leading medical cannabis company in Germany. With annual sales in Europe estimated at US$248 billion, Curaleaf is well-positioned to drive sales growth over the next decade, especially given its 2022 revenue of $1.77 billion. If rescheduling moves forward, Curaleaf could see its stock sustainably surpass the $5 mark, firmly establishing itself among the top cannabis stocks.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CURLF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

The GEO Group, Inc. (GEO)

The global government secure facilities specialist owns significant prison real estate and an extremely valuable tech platform called BI, which monitors prisoners and illegal migrants.

BI provides a GPS technology intended to enhance compliance. The electronic monitoring program tracks immigrants and prisoners via cell phones and other electronic devices. GEO has an exclusive five-year contract with ICE that ends in 2026 but will likely be renewed post-2026. This allows the company to capture 100% of the ICE market for immigrants who are under this system.

The GEO Group’s owned real estate is estimated to be worth multiples of the current enterprise value in private market transactions and BI could be worth the entire enterprise value in a spin-off or sale of the segment.

The margins are also impressive with 55% EBITDA margins and the company putting up over $270M of EBITDA in 2022 alone from the BI segment. With a share price of $7.22, GEO has a market cap of $903 million and an enterprise value of only $2.7 billion.

Citron Research thinks GEO is cheap, and the pros on Wall Street agree. The analysts covering the stock give a median 12-month target of $15, representing a 102% increase from the current price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GEO” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Taiwan Semiconductor (TSM)

Trading at a significant 37% discount from its peak in January 2022, Taiwan Semiconductor has faced challenges stemming from a decline in smartphone demand and other factors impacting PC sales. Additionally, geopolitical tensions have added an air of uncertainty. Despite concerns raised, many analysts remain optimistic, labeling TSM as a strong buy. With an average price target of $125, there’s potential for an impressive 36% upside.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”TSM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Dividend All-Stars: Smart Buys for October

Editorial Staff

September 21, 2023

The best dividend stocks belong to stable, well-established companies with a history of distributing profits to shareholders. We already know this, and I will focus on that point while also highlighting three specific dividend stocks in today’s list. Additionally, these three stocks are an attractive buy right now when you consider the most critical metrics to dividend stocks, such as:

– Dividend payout ratio: A higher ratio affirms the company’s ability to return profits to investors.

– Debt-to-equity percentage: A measure below 50% suggests healthy debt management.

– Beta score: A beta under 1.00 deems the stock safe from broader market volatility.

By choosing dividend stocks wisely, investors will enjoy a regular income stream and long-term growth potential, adding extra security and peace of mind to their portfolios…

Pioneer Natural Resources Co (PXD)

First, let’s consider investing in Pioneer Natural Resources (PXD), an established oil and gas exploration company operating primarily in the Permian Basin region of the U.S. While PXD’s Q1 revenue declined by approximately 26% year-over-year and earnings per share (EPS) also saw a significant drop, the company

managed to raise its quarterly base-plus-variable dividend by 14%. This increase indicates PXD’s commitment to rewarding its shareholders despite challenging market conditions.

PXD’s stock is only slightly down year-to-date by 0.24% and shows comforting numbers within its balance sheet. PXD comes with a positive SMA (simple moving average), positive momentum, a volatility-safe beta of 0.84, and a PEG (price/earnings to growth) ratio of 0.72x. With a D/E (debt to equity) measure of 27.05%, PXD recently beat analysts’ EPS and revenue projections by 6.01% and 0.51%, respectively. PXD has an annual dividend yield of 10.18%, a quarterly payout of $5.80 ($23.20/year) per share, and a 92.3% payout ratio. With a 10-day average volume of 1.91 million shares, PXD has a median price target of $245, with a high of $311 and a low of $196; this represents a potential 36.5% upside from where its price currently sits. PXD has 17 buy ratings and 14 hold ratings.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”PXD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Genco Shipping & Trading Ltd (GNK)

Another strong income stock to consider investing in is Genco Shipping & Trading Ltd. (GNK). The ocean transport company, with 44 vessels for dry bulk cargo, has a strong dividend history, paying out for the 15th time consecutively, showing consistency. Despite a year-over-year sales decline in Q1 2023, GNK’s Board of Directors suggested setting aside fewer earnings for investment to sustain its dividend. This, along with what you’ll read below, makes GNK a promising option for those seeking a dividend grower.

GNK’s stock is down 8.40% year-to-date and is trading near the bottom of its existing range, yet it carries a solid 0.65 beta, a low D/E of 16.51%, and a PEG ratio of 0.07x. GNK, for the current fiscal quarter, is projected to report $62.7 million in sales at $0.26 per share, with a 3-5 year EPS growth rate of 65%. GNK has a 4.26% annual dividend yield, a quarterly payout of 15 cents ($0.60/year) per share, and a 91.3% payout ratio. With a 10-day average volume of approximately 644 thousand shares, GNK has a median price target of $23, with a high of $28 and a low of $17, representing a potential 99% price jump. GNK has nine buy ratings (zero holds).

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GNK” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Eagle Bulk Shipping Inc (EGLE)

Eagle Bulk Shipping (EGLE) is an integrated shipowner and operator of midsize dry bulk vessels catering to various industries, including miners, producers, and traders. Despite facing a challenging Q1 in 2023 with a YOY revenue decline due to a downturn in the dry bulk market and lower charter rates, EGLE remains a strong contender for investors. With a diverse customer base and a resilient approach to navigating market fluctuations, EGLE presents an appealing opportunity for income investors.

EGLE is down by 11.33% year-to-date and is trading near the bottom of its existing price range; however, the stock boasts an impressive 0.18x PEG ratio, a 0.27 beta score, a positive ROE, and a 39.74% D/E measure. At its last earnings call, EGLE exceeded analysts’ EPS and revenue projections handily, most notably reporting EPS of $0.26 per share vs. $0.07 per share as predicted, a whopping 282.35% win. For the current quarter, EGLE is forecasted to show $75.7 million in sales at $0.77 per share, with a 3-5 year EPS growth rate of 59.7%. EGLE has a 0.90% annual dividend yield, a quarterly payout of 10 cents ($0.40/year) per share, and a 43.8% payout ratio. With a 10-day average volume of a modest 171 thousand shares, EGLE has a median price target of $59.55, with a high of $84 and a low of $52, which represents the potential for an almost 90% price upside. EGLE has ten buy ratings (zero holds).

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”EGLE” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Meta Platforms (META): Know the Pros and Cons Before You Decide to Buy

Editorial Staff

September 20, 2023

When we think of the big names in tech, Meta Platforms (META) obviously comes to mind—it was even quick to come to mind before it changed its name from Facebook… Remember “FAANG” stocks?

META has a great track record and is at the forefront of tech innovations today. As with most successes, though, META presents investors with various pros and cons, and one tends to outweigh the other.

While the allure of a high-stakes cage fight between big-time CEOs Elon Musk (TSLA) and Mark Zuckerberg (META) might capture our attention, we should ignore the quick headlines and instead focus on business performance. How the balance sheet looked last quarter always matters.

Looking at META’s overall performance before being swayed by market trends is prudent. Having the most precise understanding of our portfolio options can only maximize future profits…

What are META’s downsides?

It’s worth acknowledging that the current valuation of Meta Platforms could be stretched, making the stock appear overvalued in price. META’s P/E (price to earnings) ratio is about 33.2x, which contrasts with the overall sector; however, its forward-looking pricing ratios are looking brighter. I bring attention to META’s valuation discrepancy because that’s what I, for example, would tend to look at early on when reviewing stocks, and such a thing can sway investors from consideration. As with META, there’s always more going on underneath. For example, despite the elevation in META’s market capitalization throughout much of 2023, its stock price has managed to sustain its upward trajectory. It could’ve been worse.

META’s current price within its 52-week range:

[stock_market_widget type=”gauge” template=”basic” assets=”META” low_high=”52_week_low_high” red_color=”#DB2828″ yellow_color=”#FBBD08″ green_color=”#21BA45″ api=”yf”]

What are META’s upsides?

It should be noted that META, amidst its progressive success with Facebook and Instagram, looks like it might have a concern on its hands regarding its “Threads” short-form message app. Tech analysts have highlighted the fact that Threads is facing the challenge of being late to the party, as I’ll put it. META has to contend with the pressure of carving a niche for itself in the presence of already established and

accomplished competitors such as X (formerly Twitter) and TikTok. Not only is that an issue, but META has to take Threads and essentially go above and beyond what’s already been achieved with Instagram’s expansion. To put it plainly, Threads really, really needs to prove itself. That’s a tall order. Optimism continues to linger, however, due to a little thing called AI.

[stock_market_widget type=”table-quotes” template=”basic” assets=”META” fields=”logo_name_symbol,price,change_abs,change_pct,market_cap” links=”{‘META’:{}}” display_header=”true” display_chart=”true” display_currency_symbol=”true” pagination=”true” search=”false” rows_per_page=”5″ sort_field=”logo_name_symbol” sort_direction=”asc” alignment=”left” api=”yf”]

While acknowledging the downsides and the “bearish” perspective on META stock, investors should remember that the hype might just be real. It’s now crucial to highlight the robust bullish case favoring META, which ultimately seems to win out against its pessimistic counterpart.

META CPO (Chief Product Officer) Chris Cox has affirmed a proactive approach by exploring the use of more “retention-driving hooks” to enhance a user’s engagement with Threads. One example of this would be integrating the ability to enable Instagram and allowing users to access critical Threads content more efficiently. That being said, I think it remains premature to brand META’s Threads as unsuccessful.

META continues to derive substantial revenue streams from Instagram, Facebook, and WhatsApp. Its growth potential extends to the metaverse segment, encompassing sales of VR (virtual reality) headsets. It’s also crucial to point out that META is resolute in its pursuit of advancements in AI technology. Analysts are pleasantly hopeful, too, as many anticipate the introduction of innovative generative AI capabilities across all of META’s apps by September of this year. Whether or not we have another brand of ChatGPT with a few extras remains to be seen. The aforementioned “pros” or “upsides” all help bolster META’s viability as an investment opportunity. Let me try to put a spotlight on that:

[stock_market_widget type=”accordion” template=”chart” color=”#5679FF” assets=”META” start_expanded=”true” display_currency_symbol=”true” api=”yf” chart_range=”1y” chart_interval=”1d”]

META’s 1 year performance chart

META’s stock performance has absolutely lived up to the hype surrounding it. Currently, META is up year-to-date by a whopping 138.22%, with a positive 20/200 day SMA (simple moving average) and significant TTM (trailing twelve-month) growth in momentum and assets—82.63% and 21.74%, respectively. At its Q2 2023 earnings call, META exceeded analysts’ projections, reporting EPS of $2.98 per share vs. $2.89 per share as expected and revenue of $32 billion vs. $31 billion as expected. META also posted year-over-year growth in revenue (+11.02%), net income (+16.46%), EPS (+21.14%), net profit margin (+4.91%), and operating income (+21.70%). META boasts a PEG (price/earnings to growth) ratio of 0.89x and a low 14.78% D/E (debt to equity) measure. With a free cash flow of $55.5 billion and a 10-day average volume of 18.76 million shares, META has a median price target of $380, with a high of $435 and a low of $238; this suggests the potential for an almost 52% jump from where its price sits currently. META has 20 “strong buy” ratings, 32 “buy” ratings, and 5 “hold” ratings.

Three Tech Stocks Still Down 30% or More

Editorial Staff

September 20, 2023

There has been a remarkable resurgence in 2023 following last year’s bear market tumble.

The Nasdaq Composite, a key indicator for tech-focused investments, has shown a robust 32% increase year-to-date.

Nevertheless, there’s still untapped potential before it reaches its previous all-time high, and there are intriguing opportunities among stocks that have yet to fully recover from the challenges of the pandemic era.

Today, we’ll focus on three compelling tech companies with stocks that are still down more than 30%.

Taiwan Semiconductor (TSM)

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”TSM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Advanced Micro Devices (AMD)

Amidst the ebb and flow of chipmakers’ fortunes following a surge in PC sales during the pandemic, Advanced Micro Devices has seen its stock price recede by 34% since its peak in November 2021. However, as the AI industry gains momentum, AMD is well-positioned to capitalize on the growing demand for AI chips. The company’s chips are increasingly sought after as cloud infrastructure giants expand their data centers to accommodate AI-related workloads. With AMD poised to release the MI300 GPU, a formidable competitor in the AI infrastructure space, the future appears promising. Although the company has encountered challenges in specific market segments, the broader chip demand is set to rebound, making AMD an enticing prospect for investors.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”AMD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

CrowdStrike (CRWD)

Founded in 2011, CrowdStrike Holdings has been a pioneer in integrating AI and machine learning into cybersecurity. Today, it stands as a leader in cloud-based endpoint protection, using AI and machine learning to detect and thwart cyber threats. While the company has consistently delivered strong business results, its stock has weathered volatile swings due to macroeconomic pressures and a slowdown in growth. Even after substantial gains this year, CrowdStrike’s shares remain approximately 41% below their peak in November 2021.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CRWD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Buy and Hold: These Well-Known Retailers Promise Huge Future Returns

Editorial Staff

September 18, 2023

We can all see that the US relies heavily on consumption—which has been the case for years—and revenue from the retail sector plays a vital role in determining the state of the economy.

Inflation and rising interest rates in recent years have certainly affected growth in the retail sector, and overall sentiment regarding retail stocks has been mostly tepid among investors.

However, US retail sales increased by 0.7% in July. With inflation starting to settle and the holiday season soon approaching, there’s an argument to be made for investing in undervalued retail stocks. The ones I’ll cover today could also be considered passive income stocks due to their very lucrative dividend payouts.

With plenty of reasons to be optimistic about retail stocks, analysts think they have the potential to yield up to 50% in total returns by 2025, easily surpassing index returns…

Home Depot (HD)

Home Depot (HD) is a compelling choice among undervalued retail stocks, poised for an upward breakout. Despite a predicted decline of 2% in sales and 5% in comparable sales for 2023, HD maintains impressive financial stability, boasting a huge amount of free cash flow. This financial strength allows flexibility for investments, share buybacks, and dividends, as evident in HD’s recently authorized $15 billion share repurchase program. HD remains bullish on expanding its market share within the extensive retail market, and with ample resources for investments, it has strong long-term growth potential.

HD is up year-to-date by 4.39% and is trading around the middle of its 52-week high-low range. With a 0.95 beta score, which indicates safety from broader market volatility, HD has a positive 20/200 day SMA (simple moving average), an operating free cash flow of $12.75 billion, and a remarkable ROE (return on equity) of 2,065%. For its Q2 2023 earnings call, HD reported EPS of $4.65 per share vs. $4.44 per share as expected by analysts, a 4.68% surprise; it also beat analysts on revenue estimates by 1.63%. For the current fiscal quarter, HD is projected to post $37.6 billion in sales at $3.77 per share, with a 3-5 EPS growth rate of 13.5%. HD has an annual dividend yield of 2.54%, a quarterly payout of $2.09 ($8.39/year) per share, and a 51% payout ratio. With a 10-day average volume of 2.58 million shares, HD has a median price target of $350, with a high of $384 and a low of $296; this could lead to a 16.5% price increase.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”HD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Target (TGT)

Target (TGT), another prominent retailer, has encountered challenges, with a 5.4% year-over-year decline in comparable store sales for Q2 2023. Despite this setback, though, there are notable bright spots. In Q2, TGT also achieved a 27% gross margin, marking a 550 basis point improvement. As inflation eases, sustained margin enhancement is anticipated. Additionally, with the holiday season on the horizon, 2023’s second half is expected to yield positive results, potentially driving TGT upward from its undervalued position. TGT‘s ambitious $4 to $5 billion investment plan for 2023, focused on enhancing the guest experience, remodeling existing stores, and diversifying its brand portfolio, is positioned to yield favorable outcomes. TGT also works well as an excellent income stock with its handsome dividend.

TGT is currently down year-to-date by 16.27%, is trading near the very bottom of its existing 52-week range, carries a 1.01 beta, has a PEG (price/earnings to growth) ratio of 0.93x, and has an operating free cash flow of $7.46 billion. TGT, for its Q2 earnings call, reported EPS of $1.80 per share vs. $1.42 per share as expected by analysts, a 26.85% win. During the same period, TGT also reported year-over-year growth in net income (+356.28%), EPS (+361.54%), net profit margin (+381.43%), and operating income (+254.99%). For the current quarter, TGT is projected to post $26.5 billion in sales at $2.02 per share, with a 3-5 year EPS growth rate of 5.6%. With a 3.53% annual dividend yield, TGT has a quarterly payout of $1.10 ($4.40/year) per share and a 59.62% payout ratio. Having a 10-day average volume of 3.23 million shares, TGT has a median price target of $142.80, with a high of $184 and a low of $120; this indicates the potential for a price jump of over 47% from its current trading position.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”TGT” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Best Buy (BBY)

Last but certainly not least is Best Buy (BBY), and it’s worth considering adding to your portfolio as another undervalued retailer. BBY has maintained stability in the past year and boasts an appealing forward P/E ratio of 11x. Projections suggest BBY stock could bring total returns ranging from 30% to 40% in the next two years. BBY’s outlook anticipates a turning point in tech demand, with growth expected to surge due to natural upgrade and replacement cycles. This suggests a positive shift away from sales declines, and given BBY’s valuation and current trading position, there’s undoubtedly room for growth. Like its peers on the list, there’s an attractive dividend to be had by holding a piece of BBY.

Currently down year-to-date by 8.44%, BBY is trading around the bottom end of its existing 52-week range, has a 1.33x PEG ratio, a positive ROE of 45%, and a reasonably low D/E (debt to equity) figure of 40.92%. BBY carries a TTM (trailing twelve-month) free cash flow of $1.44 billion. BBY, for its Q2 2023 earnings call, reported EPS of $1.22 per share vs. $1.07 per share as predicted by analysts (a 13.35% win); it also beat revenue estimates, albeit slightly, by a 0.69% margin. For the current quarter, BBY is projected to report sales of $10 billion at $1.24 per share, with a 3-5 year EPS growth rate of 8%. BBY has a 5.01% annual dividend yield, a quarterly payout of 92 cents ($3.68/year) per share, and a 62.07% payout ratio. With a 10-day average volume of 2.19 million shares, BBY has a median price target of $81, with a high of $91 and a low of $70; this indicates the potential for a nearly 25% increase from its current price.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”BBY” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Three Stocks to Sell ASAP

Editorial Staff

September 16, 2023

The right stocks can make you rich and change your life.

The wrong stocks, though… They can do a whole lot more than just “underperform.” If only! They can eviscerate your wealth, bleeding out your hard-won profits.

They’re pure portfolio poison.

Surprisingly, not many investors want to talk about this. You certainly don’t hear about the danger in the mainstream media – until it’s too late.

That’s not to suggest they’re obscure companies – some of the “toxic stocks” I’m going to name for you are, in fact, regularly in the headlines for other reasons, often in glowing terms.

I’m going to run down the list and give you a chance to learn the names of three companies I think everyone should own instead.

But first, if you own any or all of these “toxic stocks,” sell them today…

Mullen Automotive (MULN)

Mullen Automotive has experienced a staggering 99.96% decline since November 2021, making it a prime example of a speculative investment gone awry.

MULN share price surged by 80% last week due to a stock buyback program. This and any future spikes can be viewed as a selling opportunity stock.

The company’s CEO recently expressed skepticism about the stock price’s alignment with the actual company value, emphasizing steady operational progress and the initiation of commercial vehicle production. However, interpreting market signals suggests a lack of investor confidence in the management team. Amid increasing revenue, the ongoing cash burn and the need for equity dilution raise concerns. The timing of the buyback initiative is puzzling, given the company’s apparent need for funds to support growth ventures.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”MULN” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Windtree Therapeutics (WINT)

Windtree Therapeutics, a Pennsylvania-based biotech firm, specializes in addressing advanced-stage cardiovascular disorders like cardiogenic shock and acute heart failure.

However, the current year hasn’t been favorable for the company. Windtree’s stock has experienced an 85% decline, largely attributed to its chairman, James Huang’s resignation. Huang’s departure was accompanied by statements that the company’s stock price doesn’t accurately reflect its intrinsic value. Moreover, the transfer of ownership shares from existing shareholders was acknowledged as a misstep.

The second quarter saw Windtree reporting a net loss of $6.6 million, equivalent to $1.64 per share. While the quarter generated $12.4 million in funds, the company has enough liquidity to maintain operations until the first quarter of 2024.

With five drugs in its pipeline, four of them in Phase 2 testing, WINT stock is positioned for potential growth. Ideally, the company aims to achieve revenue generation before its financial resources deplete in the upcoming year. However, if this milestone isn’t met, the possibility of seeking additional funds, potentially through equity dilution, looms.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”WINT” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Marvell Technology (MRVL)

According to Marvell Technology’s CEO, Matt Murphy,, generative AI is playing a pivotal role in attracting fresh investments from the company’s cloud-focused clientele.

Not surprisingly, MRVL stock witnessed a notable surge earlier in the summer, fueled by expectations of it emerging as a major player in the AI stock realm. However, the actual outcome has consistently fallen short of these optimistic projections.

Illustrating this, the company released its earnings report on August 24th. The company not only incurred a financial loss but also experienced an 11% year-over-year dip in revenues. Despite the touted AI revolution, it seems that Marvell is missing out on the AI momentum. With disappointing earnings and waning enthusiasm for its AI prospects, MRVL stock seems poised for a downward trajectory.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”MRVL” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Semiconductor Revolution: The Impact of ARM’s Landmark IPO

Editorial Staff

September 16, 2023

The fiscal year 2023 on Wall Street has mostly acted as a highlighter of a new, never-before-seen technology boom, and it’s starting to have a far-reaching global impact on many industries.

This enormous tech rally was kicked off by the launch of OpenAI’s ChatGPT, a generative AI (artificial intelligence) model that has since inspired a swath of competitors offering their own innovations.

As AI plays an increasingly important role in our lives, there will also be more opportunities for investors. Some of those opportunities are already here and present themselves with a very lucrative appeal.

There was one business that played an extraordinarily vital role in the manufacturing of chips, or semiconductors, that many of us weren’t aware of—until now, that is…

ARM, a UK-based pioneer in chip design, took center stage on September 14th, 2023, as it embarked on its long-awaited initial public offering (IPO). It was quite a sight and rather unexpected for many; this IPO was the largest on record since 2021, netting roughly $4.87 billion in fundraising.

With its roots tracing back to 1990, when it emerged as a joint venture between Acorn Computers, Apple, and VLSI Technology, ARM has “been there, done that,” if you will. Those in the know, including ARM’s backers and managers, are convinced that it’s poised for remarkable expansion in the years to come.

Arm Holdings, initially the brainchild of SoftBank, staged an introduction on Wall Street that made immediate waves. ARM cast its opening spell with a staggering valuation of nearly $60 billion, and what ensued was the sale of roughly 95.5 million of its shares. SoftBank, the entity that ushered ARM into the private realm in 2016, retained over 90% of the outstanding shares.

ARM’s day range:

[stock_market_widget type=”gauge” template=”basic” assets=”ARM” low_high=”day_low_high” red_color=”#DB2828″ yellow_color=”#FBBD08″ green_color=”#21BA45″ api=”yf”]

ARM set its share price at the higher end of the anticipated range. After Thursday’s opening bell, ARM’s stock commanded an impressive opening trading price of $56.10 and closed the day at $63.59.

ARM’s P/E (price to earnings) ratio leaped to over 110x based on the latest year’s profits. An engaging comparison could be drawn to Nvidia (NVDA), which trades at a 108x P/E ratio. However, ARM lacks NVDA’s staggering 170% growth forecast for the current quarter. That’s for now, at least. ARM’s CFO (Chief Financial Officer), Jason Child, has emphasized its strategic focus on nurturing growth and crafting products that offer “more for less” to its varied clientele.

[stock_market_widget type=”comparison” template=”basic” color=”#5679FF” assets=”ARM,NVDA” fields=”name,change_abs,change_pct,volume,dividend_yield,eps,pe_ratio,shares_outstanding,market_cap,chart” links=”{‘ARM’:{},’NVDA’:{}}” display_currency_symbol=”true” api=”yf” chart_range=”5d” chart_interval=”1d”]

A significant slice of ARM’s royalties originates from already prominent products. Remarkably, around half of the company’s $1.68 billion in royalty revenue for 2022 is attributed to products that made their debut between 1990 and 2012. Child eloquently likened these enduring products to the timeless Beatles discography, continually delivering royalties despite their vintage status.

In an intriguing pitch to investors, ARM shared its vision for the company, foreseeing the total market for its chip designs skyrocketing to a staggering $250 billion by 2025. This would be a huge advantage for data centers and automobiles. Also, ARM’s prowess is the backbone of nearly every smartphone chip, revealing how intricate a processor can be with its arithmetic, algorithms, and access to memory.

Notably, ARM distributed $735 million worth of its shares to a group of strategic investors, including tech titans like Alphabet, Nvidia, Apple, Samsung, AMD, Intel, and Taiwan Semiconductor, to name a few. This move is a testament to ARM’s commanding influence, as chip companies have embraced its technology to assist in their contributions to the industry.

SoftBank CEO Masayoshi Son has accentuated ARM’s role in fueling the AI revolution and how involved the business has already been in AI and ML (machine learning). He passionately expressed that he planned to hold SoftBank’s stake in ARM for the foreseeable future.

ARM’s debut can breathe fresh life into the technology IPO market, which had been in hibernation for nearly two years. This event marks the most monumental and influential tech offering in quite some time, heralding an era of enthusiasm for a new wave of AI-based technology that will indeed act as a change agent in each of our lives for years to come.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ARM” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Forget Canopy Growth Corp (CGC), These Cannabis Stocks are Poised to Win

Editorial Staff

September 15, 2023

President Joe Biden’s recent directive to review the classification of marijuana in the United States has sent ripples through both the cannabis industry and Capitol Hill. Historically, cannabis policy has been associated with left-wing causes, often met with strong opposition from Republicans. However, in what Bloomberg describes as a “rare moment of progress,” the notion of rescheduling marijuana is gaining traction from both sides of the political spectrum. This newfound optimism is fueling interest and enthusiasm in cannabis stocks.

As the industry awaits updates on potential rescheduling, investors are closely monitoring the cannabis sector, and one notable development is the remarkable surge in shares of Canada-based Canopy Growth (TSX: WEED), which have risen by almost 200% since late August. However, despite these gains, Canadian cannabis producers continue to face substantial challenges. Over the last four fiscal years, Canopy Growth has reported cumulative operating losses of nearly $3 billion, causing its share prices to plummet by 98% from all-time highs.

Amid this shifting landscape, two companies poised to benefit significantly from potential rescheduling are Green Thumb Industries (GTBIF) and Curaleaf Holdings (CURLF).

Green Thumb Industries (GTBIF)

In contrast to their Canadian counterparts grappling with various issues, multi-state operators like Green Thumb are fortifying their profit margins and positioning themselves to capitalize on economies of scale, particularly if marijuana legalization gathers momentum.

Green Thumb, with a market capitalization of $3.5 billion, strategically focuses on limited-license markets in the U.S., where competition is constrained to a select few. This strategy has enabled Green Thumb to cultivate a dedicated customer base and consistently achieve positive GAAP results for 11 consecutive quarters, setting it apart from other players in the cannabis industry. During the second quarter (Q2), Green Thumb reported sales of US$252 million, a GAAP net income of US$13 million, and an adjusted EBITDA of US$76 million, demonstrating a robust 30% margin. The company’s strong operating cash flow of US$93 million and cash reserves of US$149 million at the end of Q2 underscore its financial stability. With plans to expand its Rise retail stores, Green Thumb is projected to achieve an 18% increase in sales, reaching $1.36 billion in 2023, and a 16.3% rise in revenue to $1.6 billion in 2024. Analysts anticipate adjusted earnings to grow from $0.44 per share in 2022 to $0.57 per share in 2024, despite macroeconomic challenges. With a price-to-forward-sales ratio of 2.2 and a price-to-forward-earnings ratio of 25.6, GTBIF stock presents an enticing valuation, trading at a substantial discount to consensus price target estimates.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”GTBIF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Curaleaf Holdings (CURLF)

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”CURLF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Stock Hotlist: Top Picks for the Coming Week

Editorial Staff

September 10, 2023

Picking the wrong stocks can decimate your portfolio.

They’re pure portfolio poison.

But the right stocks…

If you pick the right stocks, you could find yourself jumping for joy on top of an enormous pile of cash.

With over 4000 tickers to choose from, finding the right stock at the right time can prove to be nearly impossible…

Unless you’re spending hours each day combing the markets and researching companies.

That’s why we’ve done the legwork for you.

We sort through thousands of stock ideas and whittle them down to a few top choices that are primed for solid price action in the coming days, weeks and months.

This week, we’ve narrowed it down to three stocks that could be getting significant attention in the near future.

Meta Platforms (META)

Meta seems to have rediscovered its momentum, which bodes well for investors. Following a challenging 2022, the parent company of Facebook and Instagram has witnessed its stock price surge by 145% this year. The company is steering away from the metaverse, adopting cost-cutting measures, and emphasizing its focus on artificial intelligence (AI). In the wake of the impact of high interest rates, META stock is now indicating a robust return to growth, positioning it as one of the potential stocks to make investors millionaires.

Furthermore, the social media powerhouse has recently released financial results that have revitalized confidence in both the company and its shares. After the Q2 earnings report, META stock soared by 8%, fueled by earnings per share of $2.98, exceeding the projected $2.91 estimated by analysts. The company generated $32 billion in revenue, surpassing consensus predictions of $31.12 billion. This growth is attributed to a rebound in digital advertising across its social media platforms. Q2 revenue experienced an 11% surge from the previous year, marking the first time the company has reported double-digit growth in this domain since the conclusion of 2021. It might just be the right time to consider a purchase.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”META” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Enbridge (ENB)

The spotlight has turned toward prominent Canadian energy transportation firm Enbridge due to its perceived undervaluation, evidenced by a 13.68% dip over the past year against a consensus price target that indicates plenty of room for growth.

Enbridge holds a significant position as a blue-chip dividend stock, boasting a substantial 7.2% yield. Notably, Enbridge is dedicated to delivering value to its shareholders, having accumulated savings of $1.2 billion since 2017. With a BBB+ credit rating, the company assures stability within the dynamic energy sector. Moreover, Enbridge’s historical resilience and strategic approach to debt utilization for capital investments contribute to its overall stability. The company’s strategic emphasis on natural gas aligns well with the evolving energy landscape, making it a potentially promising avenue for investors seeking to enhance their investment foundation.

Enbridge’s distinction among oil stocks stems from its expansive North American pipeline network. While recent stock fluctuations have occurred, the company’s fundamental role in energy infrastructure, coupled with a moderate buy consensus, hints at an appealing 18% upside potential for investors considering this opportunity.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ENB” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Accenture (ACN)

Recent developments have spotlighted the synergistic collaboration between Accenture and Nvidia, culminating in the launch of AI Lighthouse, harnessing Nvidia’s formidable AI supercomputing expertise. It’s evident that Accenture is not merely riding the AI wave but is also setting a trailblazing pace for others in the industry.

Accenture has showcased remarkable performance in 2023, marking a surge of approximately 16% year-to-date. This growth trend is solidifying its position as a compelling machine learning stock, catching the attention of many astute investors.

The recent release of third-quarter fiscal 2023 earnings has only reinforced this positive outlook. A robust revenue of $16.56 billion, exhibiting a 2.5% year-on-year increase, in combination with a net income of $2.01 billion, reflecting a substantial 13% growth, underscore the company’s operational prowess. Moreover, the diluted earnings per share (EPS) have significantly expanded by 13%, surpassing expectations by an impressive margin of 5%.Accenture’s proactive endeavors in the realm of AI and machine learning have been garnering significant attention. For investors with a discerning eye on high-potential machine learning stocks, Accenture is effectively illuminating the path toward a transformative AI-driven future.

[stock_market_widget type=”accordion” template=”extended” color=”#5679FF” assets=”ACN” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

1...343536...55 Page 35 of 55

Wiz

Spring Health

Relativity Space

Curaleaf Holdings (CURLF)

The GEO Group, Inc. (GEO)

Taiwan Semiconductor (TSM)

Pioneer Natural Resources Co (PXD)

Genco Shipping & Trading Ltd (GNK)

Eagle Bulk Shipping Inc (EGLE)

What are META’s downsides?

META’s current price within its 52-week range:

What are META’s upsides?

META’s 1 year performance chart

Taiwan Semiconductor (TSM)

Advanced Micro Devices (AMD)

CrowdStrike (CRWD)

Home Depot (HD)

Target (TGT)

Best Buy (BBY)

Mullen Automotive (MULN)

Windtree Therapeutics (WINT)

Marvell Technology (MRVL)

Green Thumb Industries (GTBIF)

Curaleaf Holdings (CURLF)

Meta Platforms (META)

Enbridge (ENB)

Accenture (ACN)

Popular Posts

My Favorites